Biosimilar products: Definitions and registration process

Creative Commons License

Dal O. H., Karadogan M., SEZER A. D.

MARMARA PHARMACEUTICAL JOURNAL, cilt.19, sa.3, ss.252-258, 2015 (ESCI) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 19 Sayı: 3
  • Basım Tarihi: 2015
  • Doi Numarası: 10.12991/mpj.20151970579
  • Dergi Adı: MARMARA PHARMACEUTICAL JOURNAL
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.252-258
  • Marmara Üniversitesi Adresli: Evet

Özet

With the developments in recombinant DNA and hybridoma technology, biological products are being used for the treatment of many diseases especially in irreversible diseases and improving the quality of life of patients. After the expiry of the patent of approved biologics, biosimilar products are being produced, registered and launched in markets.